CASIF
CASI Pharmaceuticals, Inc.Company with tickers: CASIF
CIK
1962738
CUSIP
G1933S101
Shares Outstanding
20,555,873
13F Activity (30d)
2 filings
2 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 0 |
| 2026-03-18 | Folinsbee Thomas |
Director | Other | 0 |
| 2026-03-18 | Folinsbee Thomas |
Director | Other | 0 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 0 |
| 2026-03-18 | Gao Wei R |
General Counsel | Other | 0 |
| 2026-03-18 | Zeng Xuebo |
Director | Other | 0 |
| 2026-03-18 | Wu Alex |
Director | Other | 34,168 |
| 2026-03-18 | Qian Kun |
Global Controller | Other | 0 |
| 2026-03-18 | Wu Alex |
Director | Other | 0 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 0 |
| 2026-03-18 | Wang Chunhua |
Chief Operating Officer | Other | 0 |
| 2026-03-18 | Gao Wei R |
General Counsel | Other | 0 |
| 2026-03-18 | Qian Kun |
Global Controller | Other | 0 |
| 2026-03-18 | Huang James |
Director | Other | 4,529,956 |
| 2026-03-18 | Zukiwski Alexander A |
Global Chief Medical Officer | Other | 0 |
| 2026-03-18 | Qian Kun |
Global Controller | Other | 0 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 300,000 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 100,000 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 637,644 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 44,107 |
| 2026-03-18 | Qian Kun |
Global Controller | Other | 0 |
| 2026-03-18 | Gao Wei R |
General Counsel | Other | 0 |
| 2026-03-18 | Gao Wei R |
General Counsel | Other | 0 |
| 2026-03-18 | Wu Alex |
Director | Other | 0 |
| 2026-03-18 | Huang Hai |
Global Chief Commercial Ofcr | Other | 0 |
| 2026-03-18 | Huang James |
Director | Other | 0 |
| 2026-03-18 | Wang Chunhua |
Chief Operating Officer | Other | 0 |
| 2026-03-18 | Huang Hai |
Global Chief Commercial Ofcr | Other | 0 |
| 2026-03-18 | Gao Wei R |
General Counsel | Other | 0 |
| 2026-03-18 | Huang Hai |
Global Chief Commercial Ofcr | Other | 0 |
| 2026-03-18 | Wang Chunhua |
Chief Operating Officer | Other | 0 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 753,234 |
| 2026-03-18 | Wang Chunhua |
Chief Operating Officer | Other | 0 |
| 2026-03-18 | Huang Hai |
Global Chief Commercial Ofcr | Other | 0 |
| 2026-03-18 | Wang Chunhua |
Chief Operating Officer | Other | 0 |
| 2026-03-18 | Wang Chunhua |
Chief Operating Officer | Other | 0 |
| 2026-03-18 | Gao Wei R |
General Counsel | Other | 0 |
| 2026-03-18 | Huang Hai |
Global Chief Commercial Ofcr | Other | 0 |
| 2026-03-18 | Folinsbee Thomas |
Director | Other | 0 |
| 2026-03-18 | Qian Kun |
Global Controller | Other | 0 |
| 2026-03-18 | Wang Chunhua |
Chief Operating Officer | Other | 0 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 0 |
| 2026-03-18 | Huang Hai |
Global Chief Commercial Ofcr | Other | 0 |
| 2026-03-18 | Krebs-Pohl Barbara Helene Hannelore |
Director | Other | 0 |
| 2026-03-18 | Huang Hai |
Global Chief Commercial Ofcr | Other | 0 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 0 |
| 2026-03-18 | Wu Alex |
Director | Other | 0 |
| 2026-03-18 | He Wei-Wu |
Director, 10% Owner | Other | 0 |
| 2026-03-18 | Wang Chunhua |
Chief Operating Officer | Other | 0 |
| 2026-03-18 | Qian Kun |
Global Controller | Other | 0 |
Showing 1–50 of 83 transactions